Abundant toxin-related genes in the genomes of beneficial symbionts from deep-sea hydrothermal vent mussels

  1. Lizbeth Sayavedra
  2. Manuel Kleiner
  3. Ruby Ponnudurai
  4. Silke Wetzel
  5. Eric Pelletier
  6. Valerie Barbe
  7. Nori Satoh
  8. Eiichi Shoguchi
  9. Dennis Fink
  10. Corinna Breusing
  11. Thorsten BH Reusch
  12. Philip Rosenstiel
  13. Markus B Schilhabel
  14. Dörte Becher
  15. Thomas Schweder
  16. Stephanie Markert
  17. Nicole Dubilier
  18. Jillian M Petersen  Is a corresponding author
  1. Max Planck Institute for Marine Microbiology, Germany
  2. Ernst-Moritz-Arndt-University, Germany
  3. Commissariat à l'énergie atomique et aux énergies alternatives, France
  4. Okinawa Institute of Science and Technology, Japan
  5. GEOMAR Helmholtz Centre for Ocean Research Kiel, Germany
  6. Institute of Clinical Molecular Biology, Germany
  7. Institute of Marine Biotechnology, Germany
  8. University of Vienna, Austria

Abstract

Bathymodiolus mussels live in symbiosis with intracellular sulfur-oxidizing (SOX) bacteria that provide them with nutrition. We sequenced the SOX symbiont genomes from two Bathymodiolus species. Comparison of these symbiont genomes with those of their closest relatives revealed that the symbionts have undergone genome rearrangements, and up to 35% of their genes may have been acquired by horizontal gene transfer. Many of the genes specific to the symbionts were homologs of virulence genes. We discovered an abundant and diverse array of genes similar to insecticidal toxins of nematode and aphid symbionts, and toxins of pathogens such as Yersinia and Vibrio. Transcriptomics and proteomics revealed that the SOX symbionts express the toxin-related genes (TRGs) in their hosts. We hypothesize that the symbionts use these TRGs in beneficial interactions with their host, including protection against parasites. This would explain why a mutualistic symbiont would contain such a remarkable 'arsenal' of TRGs.

Article and author information

Author details

  1. Lizbeth Sayavedra

    Max Planck Institute for Marine Microbiology, Bremen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Manuel Kleiner

    Max Planck Institute for Marine Microbiology, Bremen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Ruby Ponnudurai

    Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Silke Wetzel

    Max Planck Institute for Marine Microbiology, Bremen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Eric Pelletier

    Genoscope - Centre National de Séquençage, Commissariat à l'énergie atomique et aux énergies alternatives, Evry, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Valerie Barbe

    Genoscope - Centre National de Séquençage, Commissariat à l'énergie atomique et aux énergies alternatives, Evry, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Nori Satoh

    Marine Genomics Unit, Okinawa Institute of Science and Technology, Onna, Japan
    Competing interests
    The authors declare that no competing interests exist.
  8. Eiichi Shoguchi

    Marine Genomics Unit, Okinawa Institute of Science and Technology, Onna, Japan
    Competing interests
    The authors declare that no competing interests exist.
  9. Dennis Fink

    Max Planck Institute for Marine Microbiology, Bremen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  10. Corinna Breusing

    Evolutionary Ecology, GEOMAR Helmholtz Centre for Ocean Research Kiel, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.
  11. Thorsten BH Reusch

    Evolutionary Ecology, GEOMAR Helmholtz Centre for Ocean Research Kiel, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.
  12. Philip Rosenstiel

    Institute of Clinical Molecular Biology, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.
  13. Markus B Schilhabel

    Institute of Clinical Molecular Biology, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.
  14. Dörte Becher

    Institute of Marine Biotechnology, Greifswald, Germany
    Competing interests
    The authors declare that no competing interests exist.
  15. Thomas Schweder

    Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany
    Competing interests
    The authors declare that no competing interests exist.
  16. Stephanie Markert

    Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany
    Competing interests
    The authors declare that no competing interests exist.
  17. Nicole Dubilier

    Max Planck Institute for Marine Microbiology, Bremen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  18. Jillian M Petersen

    Department of Microbiology and Ecosystem Science, Division of Microbial Ecology, Research Network Chemistry Meets Microbiology, University of Vienna, Vienna, Austria
    For correspondence
    petersen@microbial-ecology.net
    Competing interests
    The authors declare that no competing interests exist.

Copyright

© 2015, Sayavedra et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,383
    views
  • 760
    downloads
  • 47
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Lizbeth Sayavedra
  2. Manuel Kleiner
  3. Ruby Ponnudurai
  4. Silke Wetzel
  5. Eric Pelletier
  6. Valerie Barbe
  7. Nori Satoh
  8. Eiichi Shoguchi
  9. Dennis Fink
  10. Corinna Breusing
  11. Thorsten BH Reusch
  12. Philip Rosenstiel
  13. Markus B Schilhabel
  14. Dörte Becher
  15. Thomas Schweder
  16. Stephanie Markert
  17. Nicole Dubilier
  18. Jillian M Petersen
(2015)
Abundant toxin-related genes in the genomes of beneficial symbionts from deep-sea hydrothermal vent mussels
eLife 4:e07966.
https://doi.org/10.7554/eLife.07966

Share this article

https://doi.org/10.7554/eLife.07966

Further reading

    1. Developmental Biology
    2. Genetics and Genomics
    Anne-Sophie Pepin, Patrycja A Jazwiec ... Sarah Kimmins
    Research Article Updated

    Paternal obesity has been implicated in adult-onset metabolic disease in offspring. However, the molecular mechanisms driving these paternal effects and the developmental processes involved remain poorly understood. One underexplored possibility is the role of paternally induced effects on placenta development and function. To address this, we investigated paternal high-fat diet-induced obesity in relation to sperm histone H3 lysine 4 tri-methylation signatures, the placenta transcriptome, and cellular composition. C57BL6/J male mice were fed either a control or high-fat diet for 10 weeks beginning at 6 weeks of age. Males were timed-mated with control-fed C57BL6/J females to generate pregnancies, followed by collection of sperm, and placentas at embryonic day (E)14.5. Chromatin immunoprecipitation targeting histone H3 lysine 4 tri-methylation (H3K4me3) followed by sequencing (ChIP-seq) was performed on sperm to define obesity-associated changes in enrichment. Paternal obesity corresponded with altered sperm H3K4me3 at promoters of genes involved in metabolism and development. Notably, altered sperm H3K4me3 was also localized at placental enhancers. Bulk RNA-sequencing on placentas revealed paternal obesity-associated sex-specific changes in expression of genes involved in hypoxic processes such as angiogenesis, nutrient transport, and imprinted genes, with a subset of de-regulated genes showing changes in H3K4me3 in sperm at corresponding promoters. Paternal obesity was also linked to impaired placenta development; specifically, a deconvolution analysis revealed altered trophoblast cell lineage specification. These findings implicate paternal obesity effects on placenta development and function as one potential developmental route to offspring metabolic disease.

    1. Genetics and Genomics
    Thomas J O'Brien, Ida L Barlow ... André EX Brown
    Research Article

    There are thousands of Mendelian diseases with more being discovered weekly and the majority have no approved treatments. To address this need, we require scalable approaches that are relatively inexpensive compared to traditional drug development. In the absence of a validated drug target, phenotypic screening in model organisms provides a route for identifying candidate treatments. Success requires a screenable phenotype. However, the right phenotype and assay may not be obvious for pleiotropic neuromuscular disorders. Here, we show that high-throughput imaging and quantitative phenotyping can be conducted systematically on a panel of C. elegans disease model strains. We used CRISPR genome-editing to create 25 worm models of human Mendelian diseases and phenotyped them using a single standardised assay. All but two strains were significantly different from wild-type controls in at least one feature. The observed phenotypes were diverse, but mutations of genes predicted to have related functions led to similar behavioural differences in worms. As a proof-of-concept, we performed a drug repurposing screen of an FDA-approved compound library, and identified two compounds that rescued the behavioural phenotype of a model of UNC80 deficiency. Our results show that a single assay to measure multiple phenotypes can be applied systematically to diverse Mendelian disease models. The relatively short time and low cost associated with creating and phenotyping multiple strains suggest that high-throughput worm tracking could provide a scalable approach to drug repurposing commensurate with the number of Mendelian diseases.